Khiron Reports Second Quarter 2020 Financial Results

Company achieved first High-THC cannabis sales in Colombia, continued focus towards higher margin medical businesses Company held $20 million in cash at the end of June 2020, after closing Q1 with $24 million Cash used in Q2 was $4 million compared to $12 million in Q1 and $10 million in Q4 2019 Despite COVID-19 pandemic, and with prudent cash management, Company achieved meaningful progress across itsContinue reading “Khiron Reports Second Quarter 2020 Financial Results”

Vamos Colombia! Khiron Hosts Live Virtual Medical Facility Tour

Attendees are invited to attend a real-time, interactive tour of Khiron’s recently completed Zerenia medical facility – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announced that Alvaro Torres, Khiron CEO and Director will lead a live, on-camera virtual tourContinue reading “Vamos Colombia! Khiron Hosts Live Virtual Medical Facility Tour”

Khiron Goes Green, Completing 1 Megawatt Solar Energy Park in Colombia

Solar park can generate up to 40% of the energy needs at its 5 hectare facility in Doima, Colombia Project demonstrates Khiron’s commitment to sustainability by reducing its carbon footprint by approximately 7 tons of CO2 a year, while decreasing operational energy costs – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC),Continue reading “Khiron Goes Green, Completing 1 Megawatt Solar Energy Park in Colombia”

Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners

TORONTO, June 02, 2020 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has officially commenced sales of its proprietary cultivars approved by the Colombian Institute of Agriculture (“ICA”). Blueberries hasContinue reading “Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners”

Khiron Begins Sales of First High-THC Medical Cannabis in Colombia

Khiron is the first company to receive authorization to commercialize high-THC medical cannabis magistral preparations from Colombia’s National Narcotics Fund Authorization is supplementary to the previously announced high-THC extraction and cultivation quotas from the Colombian Technical Quotas Group Effective immediately, prescriptions will be filled through Company’s ILANS clinics, with expanded distribution in Colombia as partner pharmacies receive dispensary permitsContinue reading “Khiron Begins Sales of First High-THC Medical Cannabis in Colombia”

Khiron Receives First Medical Cannabis Prescriptions for UK Patients Participating in Project Twenty21

Khiron is the exclusive Latin American supplier to Project Twenty21, a leading UK registry study enrolling up to 20,000 patients by the end of 2021, to create the largest body of evidence in Europe for the effectiveness and tolerability of medical cannabis First import of EU GMP medical cannabis products is complete Khiron branded products available toContinue reading “Khiron Receives First Medical Cannabis Prescriptions for UK Patients Participating in Project Twenty21”